Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy, to the federal newborn screening list to enable early treatment, the Department of Health and Human Services said.
The decision updates the Recommended Uniform Screening Panel (RUSP), which guides state-level newborn screening programs, following a scientific review and public comment process.
Early detection of Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD) will allow children to receive FDA-approved therapies at the most effective time, helping slow disease progression and preserve quality of life, the HHS said.
DMD, a rare genetic disorder, causes muscle degeneration, while MLD affects the brain and nervous system, which leads to loss of motor and cognitive function and early death.
Most children with DMD or MLD are diagnosed at age four or five, when significant muscle loss or neurological decline has already occurred, the HHS said.
The agency said that screening at birth could reduce years-long diagnostic delays, repeated specialist visits, and the financial and emotional strain often associated with rare diseases.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
41 Young Men Die in South Africa After Circumcision Initiation- Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game
- False fuel prices in fabricated graphics circulate in Malaysia as Iran war continues
- Step by step instructions to Pick the Right Dental specialist for Your Teeth Substitution
- Dozens killed as Angola flood death toll rises
- 10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide
- Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
- She loves to give experiences. He goes for sentimental gifts. They ask an expert: What is the perfect holiday present?
- 7 Countries Where Newcomers Feel Most Welcome, and 3 Where They Often Don’t
